Absorbable Fibrin Sealant Patch Market By Application , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Absorbable Fibrin Sealant Patch Market

The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.

Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.

However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.

Segment Review

The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

General Surgery
Cardiovascular Surgery
Wound Management
Orthopedic Surgery
Urological Surgery
Ophthalmic Surgery
Others

By End User

Hospitals and Clinics
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Johnson & Johnson
Baxter International Inc
Takeda Pharmaceutical Company Limited
Becton, Dickinson and Company.
Corza Medical
LifeBond Ltd
Surgical Specialties Corporation
Biegler GmbH
Cohera Medical Inc
Integra LifeSciences Corporation

Product Code: A323960

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Application
4.2. General Surgery
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Cardiovascular Surgery
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Wound Management
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
4.5. Orthopedic Surgery
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
4.6. Urological Surgery
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
4.7. Ophthalmic Surgery
- 4.7.1. Key Market Trends, Growth Factors and Opportunities
- 4.7.2. Market Size and Forecast, By Region
- 4.7.3. Market Share Analysis, By Country
4.8. Others
- 4.8.1. Key Market Trends, Growth Factors and Opportunities
- 4.8.2. Market Size and Forecast, By Region
- 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
5.2. Hospitals And Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Ambulatory Surgical Centers
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Application
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Absorbable Fibrin Sealant Patch Market
  - 6.2.5.1. Market Size and Forecast, By Application
  - 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Absorbable Fibrin Sealant Patch Market
  - 6.2.6.1. Market Size and Forecast, By Application
  - 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Absorbable Fibrin Sealant Patch Market
  - 6.2.7.1. Market Size and Forecast, By Application
  - 6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Application
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. Germany Absorbable Fibrin Sealant Patch Market
  - 6.3.5.1. Market Size and Forecast, By Application
  - 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. France Absorbable Fibrin Sealant Patch Market
  - 6.3.6.1. Market Size and Forecast, By Application
  - 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. UK Absorbable Fibrin Sealant Patch Market
  - 6.3.7.1. Market Size and Forecast, By Application
  - 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Italy Absorbable Fibrin Sealant Patch Market
  - 6.3.8.1. Market Size and Forecast, By Application
  - 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. Spain Absorbable Fibrin Sealant Patch Market
  - 6.3.9.1. Market Size and Forecast, By Application
  - 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest of Europe Absorbable Fibrin Sealant Patch Market
  - 6.3.10.1. Market Size and Forecast, By Application
  - 6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Application
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. Japan Absorbable Fibrin Sealant Patch Market
  - 6.4.5.1. Market Size and Forecast, By Application
  - 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. China Absorbable Fibrin Sealant Patch Market
  - 6.4.6.1. Market Size and Forecast, By Application
  - 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Absorbable Fibrin Sealant Patch Market
  - 6.4.7.1. Market Size and Forecast, By Application
  - 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. Australia Absorbable Fibrin Sealant Patch Market
  - 6.4.8.1. Market Size and Forecast, By Application
  - 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. South Korea Absorbable Fibrin Sealant Patch Market
  - 6.4.9.1. Market Size and Forecast, By Application
  - 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Absorbable Fibrin Sealant Patch Market
  - 6.4.10.1. Market Size and Forecast, By Application
  - 6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Application
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Absorbable Fibrin Sealant Patch Market
  - 6.5.5.1. Market Size and Forecast, By Application
  - 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. Saudi Arabia Absorbable Fibrin Sealant Patch Market
  - 6.5.6.1. Market Size and Forecast, By Application
  - 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. South Africa Absorbable Fibrin Sealant Patch Market
  - 6.5.7.1. Market Size and Forecast, By Application
  - 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Absorbable Fibrin Sealant Patch Market
  - 6.5.8.1. Market Size and Forecast, By Application
  - 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. Johnson And Johnson
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
8.2. Baxter International Inc
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
8.3. Takeda Pharmaceutical Company Limited
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
8.4. Becton, Dickinson And Company.
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
8.5. Corza Medical
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
8.6. LifeBond Ltd
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
8.7. Surgical Specialties Corporation
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
8.8. Biegler GmbH
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
8.9. Cohera Medical Inc
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
8.10. Integra LifeSciences Corporation
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments